NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616707-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616710-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616711-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616708-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616709-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616712-A1 European Patent Office 04 Mar 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3613427-A1 European Patent Office 26 Feb 2020
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC Application EP-3578196-A1 European Patent Office 11 Dec 2019
GENE SIGNATURES FOR CANCER DETECTION AND TREATMENT Application WO-2017158358-A1 World Intellectual Property Organisation (WIPO) 21 Sep 2017